Press Announcements > FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old

Press Announcements > FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old

FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old

The U.S. Food and Drug Administration approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years. Gardasil 9 prevents certain cancers and diseases caused by the nine HPV types covered by the vaccine.

For the FDA press release: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm622715.htm.

View